Exact Mass: 487.2031
Exact Mass Matches: 487.2031
Found 108 metabolites which its exact mass value is equals to given mass value 487.2031
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Myxothiazol
A 2,4-bi-1,3-thiazole substituted at the 4-position with a (1E,3S,4R,5E)-7-amino-3,5-dimethoxy-4-methyl-7-oxohepta-1,5-dien-1-yl] group and at the 2-position with a (2S,3E,5E)-7-methylocta-3,5-dien-2-yl group. It is an inhibitor of coenzyme Q - cytochrome c reductase. D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors
Pemigatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
Sarecycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D003879 - Dermatologic Agents
Ala Asp Pro Trp
Ala Asp Trp Pro
Ala Pro Asp Trp
Ala Pro Trp Asp
Ala Trp Asp Pro
Ala Trp Pro Asp
Asp Ala Pro Trp
Asp Ala Trp Pro
Asp Pro Ala Trp
Asp Pro Trp Ala
Asp Trp Ala Pro
Asp Trp Pro Ala
Glu Gly Pro Trp
Glu Gly Trp Pro
Glu Pro Gly Trp
Glu Pro Trp Gly
Glu Trp Gly Pro
Glu Trp Pro Gly
Gly Glu Pro Trp
Gly Glu Trp Pro
Gly Pro Glu Trp
Gly Pro Trp Glu
Gly Trp Glu Pro
Gly Trp Pro Glu
Pro Ala Asp Trp
Pro Ala Trp Asp
Pro Asp Ala Trp
Pro Asp Trp Ala
Pro Glu Gly Trp
Pro Glu Trp Gly
Pro Gly Glu Trp
Pro Gly Trp Glu
Pro Trp Ala Asp
Pro Trp Asp Ala
Pro Trp Glu Gly
Pro Trp Gly Glu
Trp Ala Asp Pro
Trp Ala Pro Asp
Trp Asp Ala Pro
Trp Asp Pro Ala
Trp Glu Gly Pro
Trp Glu Pro Gly
Trp Gly Glu Pro
Trp Gly Pro Glu
Trp Pro Ala Asp
Trp Pro Asp Ala
Trp Pro Glu Gly
Trp Pro Gly Glu
Zotatifin
C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Sarecycline
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic D003879 - Dermatologic Agents
Pemigatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EN - Fibroblast growth factor receptor (fgfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor
(+)-Myxothiazol
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents D004791 - Enzyme Inhibitors